Two isoforms of Flk-1 transcripts in early diabetic rat retinas

Current Eye Research

Volumn 37, Issue 1, 2012, Pages 73-79

  Zhang, Xinyuan ^a,b   Chen, Min ^c   Gillies, Mark C ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diabetic Retinopathy; Gene transcript; Isoforms of Flk 1; Triamcinolone Acetonide; VEGFA signalling

Indexed keywords

TRIAMCINOLONE ACETONIDE; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 83655165133     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.629766     Document Type: Article

References (17)

1. Brooks HL Jr, Caballero S Jr, Newell CK et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol. 2004;122:1801-1807. (Pubitemid 39602140)
2. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2003;110:1690-[1696] (Pubitemid 37025424)
3. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest. 1996;74:819-825. (Pubitemid 26117141)
4. Gilbert RE, Vranes D, Berka JL et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998;78:1017-1027. (Pubitemid 28378215)
5. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/ vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998;47:401-406. (Pubitemid 28104202)
6. Yin LY, Wu Y, Ballinger CA, Patterson C. Genomic structure of the human KDR/flk-1 gene. Mamm Genome. 1998;9:408-410. (Pubitemid 28259219)
7. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677-1683. (Pubitemid 21924273)
8. Wen Y, Edelman JL, Kang T, Zeng N, Sachs G. Two functional forms of vascular endothelial growth factor receptor-2/ Flk-1 mRNA are expressed in normal rat retina. J Biol Chem. 1998;273:2090-2097. (Pubitemid 28069257)
9. Z hang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the bloodretinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes. 2008;57:1026-1033.
10. Tamura H, Miyamoto K, Kiryu J et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46:1440-1444. (Pubitemid 41685887)
11. Galtier N, Gouy M, Gautier C. SeaView and Phylowin, two graphic tools for sequence alignment and molecular phylogeny. Comput Applic Biosci. 1996;12:543-548.
12. Finn RD, Tate J, Mistry J et al. The Pfam protein families database. Nucleic Acids Res. 2008;36:D281-D288. (Pubitemid 351149737)
13. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J. 2006;27:413-426. (Pubitemid 43185854)
14. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem. 2002;80: 667-677. (Pubitemid 34809975)
15. Shibuya M. Vascular endothelial growth factor (VEGF)- Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium. 2006;13:63-69. (Pubitemid 44173108)
16. Millauer B, Longhi MP, Plate KH et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 1996;56:1615-1620. (Pubitemid 26104026)
17. Joshi PB, Hirst M, Malcolm T et al. Identification of protein interaction antagonists using the repressed transactivator two-hybrid system. BioTechniques. 2007;42:635-644. (Pubitemid 46932738)